ʻO ka wehewehe pōkole:
Pinoa inoa: D-Leucine
No CAS: 328-38-1
MF: C6H13NO2
MW:131.17
Phuahana kiko'ī:
| Ka nana aku | pauda keʻokeʻo |
| ʻO ke ʻano o ka hoʻonā | ʻAʻole kala kala ʻole i ka 1N HCL(50mg/ml) |
| ʻIkepili (TLC) | hoʻokō |
| Maʻemaʻe (TLC) | ≧99.0% |
| Maʻiʻo Enantiomer (HPLC)L-enantiomer | ≦0.5% |
| Assay(EA, e like me ia) | ≧96.0% |
| Manawa mana | 2 makahiki |
| Pūʻolo | 25kg/ pahu |
| Waihona | E mālama ma kahi pouli, Hoʻopaʻa ʻia i kahi maloʻo, Ke ana wela o ka lumi |
| Kaʻahele | ma ke kai a ma ka lewa a ma ka ʻāina |
| ʻĀina i kumu | Kina |
| ʻŌlelo uku | T/T |
Nā huaʻōlelo like：
(R)-2-Amino-4-methylpentanoic acid;
D-2-Amino-4-methylpentanoicacid;
(2R) -2-amino-4-methylpentanoic acid;
D-Homo-valine;
D-2-Amino-4-methylvaleric acid;
Palapala noi：
D-Leucinehe isomer kūlohelohe ʻole o L-Leucine e hana ma ke ʻano he auto-inhibitor o ka lactic streptococci i ka moʻomeheu. Hoʻokumu ʻo D-Leucine i ka analgesia i loko o ke kanaka a hōʻike pū i ka hana inhibitory i nā moʻomeheu cell bacteria.
Loaʻa i ka D-leucine ka hana antiepileptic, ʻoi aku ka kiʻekiʻe ma mua o ka L-leucine. Hiki i ka D-leucine ke ho'opau pono i ka ma'i. In vitro, hiki i ka D-leucine ke hōʻemi i ka pūnaewele lōʻihi, akā ʻaʻohe hopena i ka hoʻoili synaptic basal.
No ka noiʻi biochemical.
Kiekie:
1. Loaʻa iā mākou ka pae ton i ka waihona, a hiki iā mākou ke hāʻawi koke i ka mea ma hope o ka loaʻa ʻana o ke kauoha.
2. Hiki ke hāʻawi ʻia ke kumukūʻai kiʻekiʻe & hoʻokūkū.
3.Quality analysis report (COA) o ka pahu hoʻouna e hāʻawi ʻia ma mua o ka hoʻouna ʻana.
4. Hiki ke hā'awi 'ia ka nīnau nīnau mea kū'ai a me nā palapala 'ike loea inā noi ma hope o ka hālāwai 'ana i kekahi huina.
5. Nui ma hope o ke kūʻai aku a hōʻoiaʻiʻo paha: E hoʻoponopono koke ʻia kekahi o kāu nīnau.
